| |
Eligible Patients (n = 80)
|
Respondents (n = 64)
|
Non-respondents (n = 16)
|
|---|
|
Age
|
75 (71–81)
|
75 (71–80)
|
77 (74–84)
|
|
Male
|
42 (52.5%)
|
34 (53.1%)
|
8 (50%)
|
|
Lives alone
|
31 (38.8%)
|
25 (39%)
|
6 (37.5%)
|
|
COPD
|
75 (93.8%)
|
60 (93.8%)
|
16 (100%)
|
|
Bronchiectasis
|
4 (5.0%)
|
4 (6.2%)
|
0
|
|
Pulmonary Fibrosis
|
1 (1.2%)
|
0
|
0
|
|
Anxiety and/or Depression
|
38 (47.5%)
|
29 (45.3%)
|
9 (56.3%)
|
|
FEV1% predicted
|
40 (31–50)
|
41 (30–50)
|
40 (32–50)
|
|
Forced expiratory ratio (%)
|
34 (29–44)
|
33 (28–45)
|
35 (30–41)
|
|
DLco
|
8 (7–10)
|
9 (7–11)
|
7 (7–9)
|
|
MMRC Dyspnoea Score
|
3 (2–4)
|
3 (2–4)
|
3 (2–4)
|
|
Home Oxygen Use
|
45 (56.3%)
|
36 (56.3%)
|
9 (56.3%)
|
|
Past completion of pulmonary rehabilitation program
|
71 (80.7%)
|
58 (90.6%)
|
13 (81.3%)
|
|
Number of ALDS appointments
|
7.5 (4–11)
|
8 (4–12)
|
6 (4–9)
|
|
Accessed specialist palliative care in ALDS clinic
|
66 (82.5%)
|
52 (81.3%)
|
14 (87.5%)
|
- Data are represented as counts or medians with frequencies or interquartile ranges respectively in parentheses. FEV1 Forced Expiratory Volume in 1 s. FVC Forced Vital Capacity. DLCO Diffusion capacity of the lung for Carbon Monoxide. mMRC Modified Medical Research Council Dyspnoea Score
